actually no, the concern is not about ownership of the manufacturing facility and direct costs of the fire - it is potential for disruption in the supply of the product to market which may hurt buyer/prescriber confidence and at this crucial stage of rampup, thereby handing market share back to competitors.
like you i am very happy mgmt's product development, that is why we're all here i guess, it is more a corporate issue and as i said this is not the first time they've been slow to inform the market.
lets remember "Companies listed on ASX are required under the Listing Rules to make announcements about their activities in order to ensure a fully informed market is maintained"
ACR Price at posting:
$2.84 Sentiment: Hold Disclosure: Held
